Please assess the completion status of the following clinical trial:

Trial Title: Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male volunteers between the ages of 20 and 50 and within 20% of their ideal body weight, without congenital abnormality or chronic disease~Exclusion Criteria:~* History of cardiovascular, pulmonary, renal, endogenous, gastrointestinal, hematologic, neurologic or hemorrhagic disease;~* Clinically significant findings on routine laboratory (hematology, serum chemistry and urinalysis) or ECG tests;~* Use of prescription drugs in the 14 days immediately prior to starting the study that had the potential to interact with the study medication;~* Use of any substance that could induce or inhibit drug metabolism enzymes

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Test and reference formulations (Type: EXPERIMENTAL): Test formulation and reference formulation given orally 7 days apart in a fasted state

Based on this trial design, predict the completion outcome and termination type (if applicable).